Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04722042 · ClinicalTrials.gov registry record · NA

Place-based Mapping in EAS Listeners

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT04722042 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04722042, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

Purpose: Investigate monaural and binaural hearing in electric-acoustic stimulation (EAS) users with place-based versus default maps. Participants: Cochlear implant recipients and normal-hearing listeners Procedures (methods): This is a prospective, longitudinal investigation of the monaural and binaural outcomes (such as speech perception, spatial hearing, and/or subjective benefit) of cochlear implant recipients listening with different programs. The programs will incorporate different patient and device variables to determine the effect on cochlear implant recipient outcomes.

Interventions

  • OTHER place-based mapping
  • OTHER default mapping

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-02-23
Est. Completion 2024-07-07
Phase NA

What the Registry Record Tells You About NCT04722042

The ClinicalTrials.gov registry entry for NCT04722042 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which place-based mapping is the first listed.

NCT04722042 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04722042 about?

NCT04722042 is a clinical study titled "Place-based Mapping in EAS Listeners". Purpose: Investigate monaural and binaural hearing in electric-acoustic stimulation (EAS) users with place-based versus default maps. Participants: Cochlear implant recipients and normal-hearing listeners Procedures (methods): This is a prospective, longitudinal investigation of the monaural and bi...

What is the current status of trial NCT04722042?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-02-23. Estimated completion is 2024-07-07.

What interventions are being tested in trial NCT04722042?

The interventions under investigation include: place-based mapping (OTHER), default mapping (OTHER).

Who is sponsoring clinical trial NCT04722042?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.